이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

InnovAge Holding 대차 대조표 상태

재무 상태 기준 확인 4/6

InnovAge Holding 의 총 주주 지분은 $298.3M 이고 총 부채는 $66.1M, 이는 부채 대 자기자본 비율을 22.2% 로 가져옵니다. 총자산과 총부채는 각각 $527.4M 및 $229.0M 입니다.

주요 정보

22.2%

부채 비율

US$66.12m

부채

이자 보상 비율	n/a
현금	US$99.33m
주식	US$298.32m
총 부채	US$229.03m
총 자산	US$527.36m

최근 재무 상태 업데이트

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Mar 15

Recent updates

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Aug 10

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Jun 08

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

Sep 13

InnovAge names Richard Feifer as chief medical officer

Aug 17

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

Jul 27

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

May 12

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Apr 14

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Mar 24

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Mar 19

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

Nov 16

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Jul 28

재무 상태 분석

단기부채: INNV 의 단기 자산 ( $153.1M )이 단기 부채( $122.0M ).

장기 부채: INNV 의 단기 자산( $153.1M )이 장기 부채( $107.1M ).

부채 대 자본 내역 및 분석

부채 수준: INNV 총 부채보다 더 많은 현금을 보유하고 있습니다.

부채 감소: 지난 5년간 INNV 의 부채비율이 감소했는지 판단하기에는 데이터가 부족합니다.

대차 대조표

현금 런웨이 분석

과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.

안정적인 현금 활주로: INNV 현재 무료 현금 흐름을 기준으로 1년 이상 충분한 현금 활주로를 보유하고 있습니다.

예측 현금 활주로: INNV 의 여유 현금 흐름이 역사적 비율에 따라 계속 증가하거나 감소하는 경우 충분한 현금 활주로가 있는지 판단하기에는 데이터가 부족합니다.

InnovAge Holding 대차 대조표 상태

재무 상태 기준 확인 4/6

주요 정보

최근 재무 상태 업데이트

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Recent updates

InnovAge Holding Corp. (NasdaqGS:INNV) announces an Equity Buyback for $5 million worth of its shares.

New minor risk - Share price stability

InnovAge Holding Corp. Appoints John Koehn as Senior Vice President of External Affairs

Price target decreased by 12% to US$6.00

InnovAge Holding Corp. Reiterates Financial Guidance for the Full Fiscal Year 2024

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)

InnovAge Holding Corp. to Report Q3, 2024 Results on May 07, 2024

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Price target decreased by 9.3% to US$6.50

Consensus EPS estimates fall by 18%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024

InnovAge Holding Corp. to Report Q2, 2024 Results on Feb 06, 2024

Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)

Consensus EPS estimates fall by 113%

Consensus EPS estimates fall by 127%, revenue upgraded

First quarter 2024 earnings: EPS misses analyst expectations

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

InnovAge Holding Corp. to Report Q1, 2024 Results on Nov 07, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

Consensus EPS estimates fall by 60%

Price target decreased by 8.3% to US$7.33

InnovAge Holding Corp. Provides Full Fiscal Year 2024 Financial Guidance

Full year 2023 earnings: EPS misses analyst expectations

InnovAge Holding Corp. to Report Q4, 2023 Results on Sep 12, 2023

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Now 21% undervalued

InnovAge Holding Corp. Announces CFO Changes

Now 20% undervalued after recent price drop

InnovAge Holding Corp.(NasdaqGS:INNV) dropped from Russell Small Cap Comp Value Index

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Now 24% undervalued after recent price drop

Third quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.24 loss

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

InnovAge Holding Corp. to Report Q2, 2023 Results on Feb 07, 2023

Price target increased to US$7.00

High number of new and inexperienced directors

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2022

InnovAge Holding Corp. to Report Q1, 2023 Results on Nov 08, 2022

InnovAge Holding Corp. Not Provides Earnings Guidance for the Fiscal Year 2023

Investor sentiment improved over the past week

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

InnovAge Holding Corp. to Report Q4, 2022 Results on Sep 13, 2022

InnovAge Holding Corp. Appoints Kathy Andreasen as Chief People Officer

InnovAge Holding Corp. Names Richard Feifer as Chief Medical Officer

InnovAge names Richard Feifer as chief medical officer

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

InnovAge Appoints James Carlson to Its Board of Directors and as Non-Executive Chairman

Investor sentiment deteriorated over the past week

Consensus forecasts updated

Price target decreased to US$4.70

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Price target decreased to US$5.00

Less than half of directors are independent

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Kaskela Law LLC Announces Class Action Lawsuit Against Innovage Holding Corp. and Encourages Long-Term Investors to Contact the Firm

InnovAge Holding Corp. to Report Q2, 2022 Results on Feb 09, 2022

InnovAge Holding Corp. Withdraws Fiscal Year 2022 Guidance

Investor sentiment deteriorated over the past week

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

First quarter 2022 earnings released: EPS US$0.057 (vs US$0.15 loss in 1Q 2021)

Full year 2021 earnings released: US$0.36 loss per share (vs US$0.20 profit in FY 2020)

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2022

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Third quarter 2021 earnings released: US$0.087 loss per share (vs US$0.076 profit in 3Q 2020)

InnovAge Holding Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of Fiscal 2021

President recently bought US$249k worth of stock